IMV Inc. (IMVIF)
OTCMKTS · Delayed Price · Currency is USD
0.0000
-0.0001 (-99.00%)
At close: Jul 23, 2025
IMV Inc. Market Cap
IMV Inc. has a market cap or net worth of $15.00 as of August 22, 2025. Its market cap has decreased by -100.00% in one year.
Market Cap
15.00
Enterprise Value
n/a
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.00
Market Cap Chart
Since May 25, 2012, IMV Inc.'s market cap has decreased from 17.18M to 15.00, a decrease of -100.00%. That is a compound annual growth rate of -65.33%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 23, 2025 | 15.00 | - |
| Dec 30, 2024 | 15.00 | -99.94% |
| Dec 29, 2023 | 25.77K | -99.92% |
| Dec 30, 2022 | 30.60M | -69.46% |
| Dec 31, 2021 | 100.21M | -51.51% |
| Dec 31, 2020 | 206.65M | 40.74% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Nika Pharmaceuticals | 972.93M |
| Veradigm | 823.67M |
| Glass House Brands | 633.65M |
| Tian'an Technology Group | 628.15M |
| Elite Pharmaceuticals | 594.33M |
| American Oncology Network | 385.33M |
| CytoDyn | 372.33M |
| Northwest Biotherapeutics | 368.43M |